Effect of Short-term Motilitone Therapy on Health-related Quality of Life in PD Patients With Gastrointestinal Symptoms
Status:
Completed
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether DA-9701(Motilitone) is effective and safe
for the treatment on health-related quality of life in Parkinson's disease (PD) patients with
gastrointestinal symptoms.
Phase:
Phase 4
Details
Lead Sponsor:
Seoul National University Hospital
Collaborators:
Hanyang University Korea University Guro Hospital Samsung Medical Center Seoul Veterans Hospital SMG-SNU Boramae Medical Center